Investor Presentaiton
India Business at a glance
No. 1 in India
.
• No. 1 ranked with 8.5% market share
Market Position**
SUN
PHARMA
Prescription Ranking##
•
Chronic Segment
•
Acute Segment
Product Offering
Strong Brand Positioning**
De-risked Growth**
Extensive Sales Force
.
• Growth of 6% equal to average industry growth of 6%
•
•
No. 1 ranked by prescriptions with 13 different classes of doctors
Market leader in the chronic segment
Strong positioning in the acute segment
• Specializes in technically complex products and offers a complete
therapy basket
30 brands in the country's top 300 pharmaceutical brands
Top 10 Brands contribute approx. 18% of India revenues
Growth driven by a basket of brands - low product concentration
• 9,200+ strong field force covering over 600,000* doctors
** - As per AIOCD AWACS data for 12 months ended March'18
## As per SMSRC data for Feb'18
-
© Sun Pharmaceutical Industries Limited. All Rights Reserved.
* Does not exclude overlaps
21View entire presentation